MedTrace Logo

Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

NCT01014507 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-06-25

No results posted yet for this study

Summary

This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive

Conditions

  • Hodgkins Lymphoma

Interventions

DRUG

8 cycles BEACOPPesc plus oral contraceptive

DRUG

8 cycles BEACOPPesc plus Goserelin

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2009-09-30
Completion
2009-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01014507 on ClinicalTrials.gov